English
Segment disclosures
Company overviewAmphastar Pharmaceuticals, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Active Pharmaceutical Ingredient Segment
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:ActivePharmaceuticalIngredientSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 1462000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6689000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3535000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5227000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1692000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 14122000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4190000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4190000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11048000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11048000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2846000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2846000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 6858000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 6858000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4012000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4012000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 12482000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 12482000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 3009000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 3009000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 10175000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 10175000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3344000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 3344000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 7166000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 7166000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 3822000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 3822000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 18198000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 18198000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 18198000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 3208000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 3208000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 15287000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 15287000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 6941000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 6941000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 12079000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 12079000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 5138000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 5138000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 18478000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 18478000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 18478000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 2096000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 2096000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 10357000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 10357000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 4871000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 4871000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 8261000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 8261000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 3390000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 3390000 | Unit1 | 20200511 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 5386000 | Unit1 | 20200316 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 20357000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 20357000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 20357000 | Unit1 | 20200316 | Open filing evidence |
Finished Pharmaceutical Products Segment
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 183903000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 355074000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 171171000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 191840000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 536782000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 174414000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 174414000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 344942000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 344942000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 170528000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 170528000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 191214000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 189752000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 545444000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 538755000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 182394000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 178859000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 354230000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 349003000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 170144000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 171836000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 630273000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 176366000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 176366000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 455242000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 455242000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 142866000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 142866000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 278876000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 278876000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 136010000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 136010000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 486505000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 486505000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 117120000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 117120000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 353789000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 353789000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 120123000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 120123000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 236669000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 236669000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 116546000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 116546000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 419570000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 419570000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 419570000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 108990000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 108990000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 301594000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 301594000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 94722000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 94722000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 192604000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 192604000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 97882000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 97882000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 331368000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 331368000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 331368000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 81335000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 81335000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 243568000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 243568000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 80935000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 80935000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 162233000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 162233000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 81298000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 81298000 | Unit1 | 20200511 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 77997000 | Unit1 | 20200316 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 302000000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 302000000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 302000000 | Unit1 | 20200316 | Open filing evidence |
Finished Pharmaceutical Products Segment · Baqsimi
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:BaqsimiMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 45503000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 77937000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 32434000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 53608000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 138650000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 46687000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 46687000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 85042000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 85042000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 38355000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 38355000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 40409000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 26055000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 85106000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 73077000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 30854000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 30854000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 44697000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 44697000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 13843000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 13843000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 51157000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 24834000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 28701000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 64837000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 28701000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
Finished Pharmaceutical Products Segment · Baqsimi Neb
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:BaqsimiNebMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 2395000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 19608000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3006000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 17213000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 14207000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 28701000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 28701000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
Finished Pharmaceutical Products Segment · Enoxaparin
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:EnoxaparinMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 5615000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 17984000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5273000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 12369000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7096000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 31533000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 7702000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 7702000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 25441000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 25441000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 7872000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 7872000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 17739000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 17739000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 9867000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 9867000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 34950000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 34950000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 7983000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 7983000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 27138000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 27138000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 9031000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 9031000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 19155000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 19155000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10124000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10124000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 35962000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 35962000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 35962000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 8034000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 8034000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 28020000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 28020000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 9328000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 9328000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 19986000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 19986000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 10658000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 10658000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 48681000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 48681000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 48681000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 11647000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 11647000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 31033000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 31033000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 10218000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 10218000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 19386000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 19386000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 9168000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 9168000 | Unit1 | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 42695000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 42695000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 42695000 | Unit1 | 20200316 | Open filing evidence |
Finished Pharmaceutical Products Segment · Epinephrine
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:EpinephrineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 15854000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 35067000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 19213000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 18789000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 53556000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 16180000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 16180000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 34767000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 34767000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 18587000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 18587000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 21341000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 26792000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 75392000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 82700000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 27941000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 27941000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 54051000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 54051000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 26110000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 26110000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 81650000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 29514000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 20199000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 82486000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 57004000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 16714000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 16714000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 36805000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 36805000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 20091000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 20091000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 74204000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 74204000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 19502000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 19502000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 52777000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 52777000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 18119000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 18119000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 33275000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 33275000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 15156000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 15156000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 57530000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 57530000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 57530000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 13892000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 13892000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 38662000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 38662000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 9192000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 9192000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 24770000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 24770000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 15578000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 15578000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 23799000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 23799000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 23799000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 5370000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 5370000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 16317000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 16317000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 6957000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 6957000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 10947000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 10947000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 3990000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 3990000 | Unit1 | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 13885000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 13885000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 13885000 | Unit1 | 20200316 | Open filing evidence |
Finished Pharmaceutical Products Segment · Finished Pharmaceutical Products Net Revenues
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:FinishedPharmaceuticalProductsNetRevenuesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 187357000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 519147000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 175853000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 331790000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 155937000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 579116000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 147665000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 147665000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 426541000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 426541000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 142866000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 278876000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 486505000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 117120000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 353789000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 419570000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
Finished Pharmaceutical Products Segment · Glucagon
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:GlucagonMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 11905000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 21075000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 9170000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 13558000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 55003000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 20602000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 20602000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 41445000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 41445000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 20843000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 20843000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 26792000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 40409000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 82700000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 85106000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 27373000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 27373000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 55908000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 55908000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 28535000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 28535000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 113684000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 29514000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 82486000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 27276000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 27276000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 52972000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 52972000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 25696000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 25696000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 55322000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 55322000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 14224000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 12621000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 37003000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 39253000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 16042000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 11795000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 26632000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 22779000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10984000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10984000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 47639000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 47639000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 47639000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 12189000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 11649000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 32304000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 32314000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 12131000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 11594000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 20115000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 20665000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 7984000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 7984000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
Finished Pharmaceutical Products Segment · Ipratropium Bromide
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:IpratropiumBromideMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 8411000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 8411000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
Finished Pharmaceutical Products Segment · Lidocaine
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:LidocaineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 15039000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 28499000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 13460000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 12932000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 41575000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 14999000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 14999000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 28643000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 28643000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 13644000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 13644000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 15884000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 15884000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 41457000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 41457000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 12800000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 12800000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 25573000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 25573000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 12773000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 12773000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 58162000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 15522000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 15522000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 43174000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 43174000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 14006000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 14006000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 27652000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 27652000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 13646000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 13646000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 52539000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 52539000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 12621000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 13978000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 39253000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 37834000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 13381000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 16042000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 23856000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 26632000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10590000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10590000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 44413000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 44413000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 44413000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 11649000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 11591000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 32314000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 31577000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 11594000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 10421000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 20665000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 19986000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 9071000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 9071000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 41113000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 41113000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 41113000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 10657000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 10657000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 28922000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 28922000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 7608000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 7608000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 18265000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 18265000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 10657000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 10657000 | Unit1 | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 46013000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 46013000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 46013000 | Unit1 | 20200316 | Open filing evidence |
Finished Pharmaceutical Products Segment · Medroxyprogesterone
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:MedroxyprogesteroneMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 27850000 | Unit1 | 20200316 | Open filing evidence |
Finished Pharmaceutical Products Segment · Naloxone
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:NaloxoneMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 4037000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 12124000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3800000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 8087000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4287000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 19004000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4715000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4715000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 14774000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 14774000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5102000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5102000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10059000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10059000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4957000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4957000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 26269000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 26269000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 6818000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 6818000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 21424000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 21424000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 7193000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 7193000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 14606000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 14606000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7413000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7413000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 27540000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 27540000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 27540000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 8028000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 8028000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 20994000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 20994000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 6625000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 6625000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 12966000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 12966000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 6341000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 6341000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 33416000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 33416000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 33416000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 8739000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 8739000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 26337000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 26337000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 8723000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 8723000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 17598000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 17598000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 8875000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 8875000 | Unit1 | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 34761000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 34761000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 34761000 | Unit1 | 20200316 | Open filing evidence |
Finished Pharmaceutical Products Segment · Other Finished Pharmaceutical Products
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:OtherFinishedPharmaceuticalProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 35503000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 99309000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 34652000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 63806000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 29154000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 140823000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 37730000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 37730000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 105808000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 105808000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 37521000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 37521000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 68078000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 68078000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 30557000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 30557000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 109412000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 109412000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 23635000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 23635000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 76330000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 76330000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 25588000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 25588000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 52695000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 52695000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 27107000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 27107000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 87875000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 87875000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 87875000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 27046000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 27046000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 66099000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 66099000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 18751000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 18751000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 39053000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 39053000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 20302000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 20302000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 89988000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 89988000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 89988000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 21464000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 21464000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 70438000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 70438000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 24272000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 24272000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 48974000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 48974000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 24702000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 24702000 | Unit1 | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 100795000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 72945000 | Unit1 | 20200316 | Open filing evidence |
Finished Pharmaceutical Products Segment · Other Products
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:OtherProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 66187000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 133318000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 67131000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 64145000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 167259000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 53066000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 53066000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 103114000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 103114000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 50048000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 50048000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 58338000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 168104000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 57564000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 109766000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 52202000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
Finished Pharmaceutical Products Segment · Other Revenues
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:OtherRevenuesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 2395000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 19608000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3006000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 17213000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 14207000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
Finished Pharmaceutical Products Segment · Phytonadione
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:PhytonadioneMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 11721000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 31998000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 10304000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 20277000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 9973000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 44939000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 7449000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 7449000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 33017000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 33017000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 17855000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 17855000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 25568000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 25568000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 7713000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 7713000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 49500000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 49500000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 13978000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 14224000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 37834000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 37003000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 11795000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 13381000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 22779000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 23856000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10475000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10475000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 45498000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 45498000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 45498000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 11591000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 12189000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 31577000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 32304000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 10421000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 12131000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 19986000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 20115000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 9565000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 9565000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 42646000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 42646000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 42646000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 10470000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 10470000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 32188000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 32188000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 10689000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 10689000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 21718000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 21718000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 11029000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 11029000 | Unit1 | 20200511 | Open filing evidence |
Finished Pharmaceutical Products Segment · Primatenemist
Statement Business Segments · Subsegments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:PrimatenemistMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 21004000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 50767000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 29763000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 28808000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 80739000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 22880000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 22880000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 51931000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 51931000 | Unit_Standard_USD_nUTgKG4CHEyKSOYOeHgfaQ | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 29051000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 29051000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 26055000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 21341000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 73077000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 75392000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 22856000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 22856000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 47022000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 47022000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 24166000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 24166000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 89321000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 20199000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 24834000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 57004000 | Unit_Standard_USD_CiVho3nN20GDKn7Lg-kmjA | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 64837000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 16520000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 16520000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 40003000 | Unit_Standard_USD_Gx6euaJtZkWfmkWWKFqXdQ | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 40003000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 23483000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 23483000 | Unit_Standard_USD_l5cU1vlU6kWzInfNcE0mGQ | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 84309000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 84309000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 18359000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 18359000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 62030000 | Unit_Standard_USD_kCznergeZEGwnTLXvPCbSw | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 62030000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 18974000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 18974000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 43671000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 43671000 | Unit_Standard_USD_xX-GEPHb7EW72vsUxN7wiw | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 24697000 | Unit_Standard_USD_A2R9Kf6m4kaenF3kBYRJeA | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 24697000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 73113000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 73113000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 73113000 | Unit_Standard_USD_qQ6vd7RVgUa4rHFvgaNjYA | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 16561000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 16561000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 51624000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 51624000 | Unit_Standard_USD_UYApP6oM-0yHvMJrU29W1Q | 20221108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 16680000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 16680000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 35063000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 35063000 | Unit_Standard_USD_s_SLsXKU8kiRg7_RNqiWQw | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 18383000 | Unit_Standard_USD_Tft0B8a4IUCZN6AMt6SWpQ | 20220510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 18383000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 51725000 | Unit_Standard_USD_jKWrtx_mc0eEf9cOgh0WEA | 20230301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 51725000 | Unit_Standard_USD_M2A5txfRiUKBRQo5VdiPYw | 20210315 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 51725000 | Unit_Standard_USD_PaJvLScPx0CtzhgyQimr9A | 20220311 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 12988000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 12988000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 38333000 | Unit_Standard_USD__CTmp0PkFUu3Kh0PepwOEg | 20211109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 38333000 | Unit_Standard_USD_53r-YSdH0keWJKwxomCDjg | 20201106 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 12468000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 12468000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 25345000 | Unit_Standard_USD_1X_NFDdCmUqEcTJ69d-5Eg | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 25345000 | Unit_Standard_USD_4WVKH8fx6kCO3D47NheNew | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 12877000 | Unit_Standard_USD_VJqNhq5d2E6hWIy7vqnbvA | 20210507 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 12877000 | Unit1 | 20200511 | Open filing evidence |
Finished Pharmaceutical Products Segment · Total Net Revenues By Product
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:FinishedPharmaceuticalProductsSegmentMember;us-gaap:SubsegmentsAxis=amph:TotalNetRevenuesByProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 191840000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 536782000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 174414000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 344942000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 170528000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 188819000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 525836000 | Unit_Standard_USD_43IE2MkM1kCVfSG1yZTeOg | 20251106 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 179388000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 337017000 | Unit_Standard_USD_6mds_mDeq0Kd7LndYsukiw | 20250807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 157629000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
Pharmaceutical Products Segment
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=amph:PharmaceuticalProductsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 171171000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 719887000 | Unit_Standard_USD_EPj2TWUds0qIZ9qMADn5Ew | 20260226 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 170528000 | Unit_Standard_USD_D2nxMIj4gE-67J8DqHZkTw | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 170528000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 731967000 | Unit_Standard_USD_EPj2TWUds0qIZ9qMADn5Ew | 20260226 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 731967000 | Unit_Standard_USD_Qp3oAT26lEeEixdhOKAC7w | 20250303 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 171836000 | Unit_Standard_USD_vnSsz8lAa0OkbHoW_FEoKg | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 644395000 | Unit_Standard_USD_EPj2TWUds0qIZ9qMADn5Ew | 20260226 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 644395000 | Unit_Standard_USD_Qp3oAT26lEeEixdhOKAC7w | 20250303 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 498987000 | Unit_Standard_USD_Qp3oAT26lEeEixdhOKAC7w | 20250303 | Open filing evidence |